Prestige Consumer Healthcare, Inc. (PBH)
49.32
-0.41
(-0.82%)
USD |
NYSE |
Nov 03, 15:16
Prestige Consumer Healthcare Cash and Short Term Investments (Quarterly) : 89.13M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 89.13M |
| March 31, 2026 | 63.87M |
| December 31, 2025 | 62.37M |
| September 30, 2025 | 119.11M |
| June 30, 2025 | 139.50M |
| March 31, 2025 | 97.88M |
| December 31, 2024 | 50.87M |
| September 30, 2024 | 51.54M |
| June 30, 2024 | 34.26M |
| March 31, 2024 | 46.47M |
| December 31, 2023 | 63.62M |
| September 30, 2023 | 60.07M |
| June 30, 2023 | 54.58M |
| March 31, 2023 | 58.49M |
| December 31, 2022 | 86.36M |
| September 30, 2022 | 42.44M |
| June 30, 2022 | 35.87M |
| March 31, 2022 | 27.18M |
| December 31, 2021 | 21.02M |
| September 30, 2021 | 42.82M |
| June 30, 2021 | 163.62M |
| March 31, 2021 | 32.30M |
| December 31, 2020 | 62.10M |
| September 30, 2020 | 26.60M |
| June 30, 2020 | 57.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 94.76M |
| December 31, 2019 | 28.59M |
| September 30, 2019 | 27.90M |
| June 30, 2019 | 29.04M |
| March 31, 2019 | 27.53M |
| December 31, 2018 | 24.67M |
| September 30, 2018 | 36.91M |
| June 30, 2018 | 34.27M |
| March 31, 2018 | 32.55M |
| December 31, 2017 | 45.38M |
| September 30, 2017 | 42.98M |
| June 30, 2017 | 44.14M |
| March 31, 2017 | 41.86M |
| December 31, 2016 | 63.29M |
| September 30, 2016 | 30.46M |
| June 30, 2016 | 28.88M |
| March 31, 2016 | 27.23M |
| December 31, 2015 | 48.97M |
| September 30, 2015 | 22.15M |
| June 30, 2015 | 21.60M |
| March 31, 2015 | 21.32M |
| December 31, 2014 | 21.95M |
| September 30, 2014 | 21.75M |
| June 30, 2014 | 15.68M |
| March 31, 2014 | 28.33M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Supernus Pharmaceuticals, Inc. | 359.46M |
| Phibro Animal Health Corp. | 81.99M |
| Structure Therapeutics, Inc. | 1.343B |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Corcept Therapeutics, Inc. | 308.20M |